| |
| |
|
| Insider
Information: |
Bellinger Andrew |
| Relationship: |
CSO & CMO |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
42,629 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
42,629 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Verve Therapeutics, Inc. |
VERV |
CSO & CMO |
2022-12-14 |
42,629 |
2021-06-21 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VERV |
Verve Therapeutics, Inc. |
CSO & CMO |
• – – |
2022-12-14 |
4 |
OE |
$2.87 |
$103,320 |
D/D |
36,000 |
42,629 |
0 |
- |
|
| VERV |
Verve Therapeutics, Inc. |
CSO & CMO |
• – – |
2022-12-01 |
4 |
S |
$22.95 |
$19,852 |
D/D |
(865) |
6,629 |
0 |
- |
|
| VERV |
Verve Therapeutics, Inc. |
CSO & CMO |
• – – |
2022-10-28 |
4 |
AS |
$39.90 |
$399,000 |
D/D |
(10,000) |
6,629 |
0 |
- |
|
| VERV |
Verve Therapeutics, Inc. |
CSO & CMO |
• – – |
2022-10-28 |
4 |
OE |
$1.48 |
$14,800 |
D/D |
10,000 |
16,629 |
0 |
- |
|
| VERV |
Verve Therapeutics, Inc. |
CSO & CMO |
• – – |
2022-09-23 |
4 |
AS |
$34.67 |
$2,120,392 |
D/D |
(60,000) |
6,629 |
0 |
- |
|
| VERV |
Verve Therapeutics, Inc. |
CSO & CMO |
• – – |
2022-09-23 |
4 |
OE |
$1.48 |
$88,800 |
D/D |
60,000 |
46,629 |
0 |
- |
|
| VERV |
Verve Therapeutics, Inc. |
CSO & CMO |
• – – |
2022-07-20 |
4 |
OE |
$1.39 |
$27,800 |
D/D |
20,000 |
26,629 |
0 |
- |
|
| VERV |
Verve Therapeutics, Inc. |
CSO & CMO |
• – – |
2022-07-20 |
4 |
AS |
$34.90 |
$698,000 |
D/D |
(20,000) |
6,629 |
0 |
- |
|
| VERV |
Verve Therapeutics, Inc. |
CSO & CMO |
• – – |
2022-07-13 |
4 |
AS |
$24.90 |
$249,000 |
D/D |
(10,000) |
6,629 |
0 |
- |
|
| VERV |
Verve Therapeutics, Inc. |
CSO & CMO |
• – – |
2022-07-13 |
4 |
OE |
$1.48 |
$14,800 |
D/D |
10,000 |
16,629 |
0 |
- |
|
| VERV |
Verve Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-12-22 |
4 |
AS |
$37.42 |
$580,469 |
D/D |
(15,000) |
5,000 |
0 |
- |
|
| VERV |
Verve Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-12-22 |
4 |
OE |
$1.48 |
$22,200 |
D/D |
15,000 |
20,000 |
0 |
- |
|
| VERV |
Verve Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-06-21 |
4 |
B |
$19.00 |
$95,000 |
D/D |
5,000 |
5,000 |
2.74 |
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
